Renal Cancer

	11/19/2009	Modifying Treatment, Maximizing Benefit: A Case-Based Exploration of Advanced CRC Management
	08/12/2009	Expanding Options for First-Line Treatment of Advanced Kidney Cancer: How Can We Choose the Right Treatment for the Right Patient?
	07/15/2009	Established and Emerging Therapies for Renal Cell Carcinoma: Clinical Highlights From the 2009 Meeting in Orlando
	07/15/2009	Changing Landscape of Treatment of Advanced RCC: What Are the Implications of the Latest Findings From Key First-Line Studies?
	07/15/2009	New Agents and Combinations for Advanced RCC: Taking Stock of the Latest Research
	05/11/2009	Clinical and Research Advances in Renal Cell Carcinoma: Updates From the 2009 Genitourinary Cancers Symposium
	05/11/2009	Defining the Role of New Targeted Therapies in RCC: Latest Data, New Options, and Evidence-Based Recommendations
	05/11/2009	Finding New Ways to Refine the Treatment of RCC: Research Highlights in Prognostication, Prediction of Toxicity, and Resistance Mechanisms
	03/10/2009	Early and Aggressive Management of Treatment-Related Adverse Effects Is Essential for Achieving Optimal Clinical Outcome With Targeted Therapies in Patients With Kidney Cancer
	02/24/2009	Management of Small Renal Masses: What is the Best Management Option in This Case?
	02/23/2009	Management of Small Renal Masses: The Role of Percutaneous Biopsy
	02/20/2009	Initial Systemic Therapy Options
	02/19/2009	Current Role of Cytoreductive Nephrectomy
	12/19/2008	mTOR Inhibitors in RCC and Other Solid Tumors: Preventing Deleterious Effects of Abnormal Signaling in Key Pathways
	03/13/2008	New Science and Therapeutic Advances in the Treatment of Renal Cell Carcinoma: A Case Study Review